Abstract:Objective: Hypertension is a complex disease with a strong genetic component. Genome wide association studies (GWAS) have identified hundreds of variants associated with hypertension and its defining traits [systolic blood pressure(SBP), diastolic blood pressure(DBP), pulse pressure(PP)]. Our goal was to catalogue all sentinel variants identified by GWAS of hypertension and investigate their functional effects on transcription/translation in silico. Design and method: We compiled a list of all common (minor allele frequency >0.05) sentinel variants associated with SBP, DBP and PP in at least one GWAS at genome-wide level of statistical significance (P < 5x10-8). In silico analyses were conducted to characterise putative biological consequences of these variants at mRNA/protein level. All sentinel variants (and their statistical proxies) were characterised using Ensembl variant effect predictor (VEP) GRCh37 release 90 to identify effects on coding and non-coding exons. Data from the University of California Santa Cruz (UCSC) CpG islands was used to map variants to regulatory regions of open chromatin. Combined Annotation Dependent Depletion (CADD) scores quantified the overall genetic deleteriousness of variants. Results: A total of 892 variants were significantly associated with at least one BP-defining trait in GWAS. The effects of each allele copy of these variants on blood pressure ranged from 0.15–1.58mmHg (for SBP) and 0.09–0.81mmHg (for DBP). A total of 599 (67%) variants received at least one functional annotation. Only 92 (10.3%) variants led to missense changes in encoded proteins. A significant number of variants directly mapped to regulatory regions of active chromatin such as active enhancers and transcription start sites [258 (28.9%) and 225 (25.2%), respectively]. Only three variants [rs16859180 in the gene Serine/Threonine Kinase 36(STK36), rs328 in lipoprotein lipase(LPL) and rs11556924 in zinc finger C3HC-type protein 1(ZC3HC1)] had CADD scores >30 (placing them in the top 0.1% of most deleterious variants in the human genome). Conclusions: The majority of BP GWAS variants do not alter the amino-acid content of encoded proteins. A significant proportion are located within regions of regulatory importance to transcription, suggesting that many BP GWAS variants operate through quantitative effect on expression of key genes in specific cells and tissues.

Genome-Wide Association Studies of Hypertension and Several Other Cardiovascular Diseases.

Heart Genomics

Advances in Genome-Wide Association Studies on Essential Hyperten-Sion

Genome-Wide Association Studies: Contribution of Genomics to Understanding Blood Pressure and Essential Hypertension

Genetics of hypertension and cardiovascular disease and their interconnected pathways: lessons from large studies

Beyond genome-wide association studies: new strategies for identifying genetic determinants of hypertension

Genome-wide association study in Chinese identifies novel loci for blood pressure and hypertension

Multi-trait genome-wide analysis identified novel risk loci and candidate drugs for heart failure

Population Genomics of Heart Diseases and Risk Factors: Going Wider and Deeper

Causal relevance of different blood pressure traits on risk of cardiovascular diseases: GWAS and Mendelian randomisation in 100,000 Chinese adults

INTRINSIC GENETIC FACTORS WERE INCONSISTENTLY REPORTED FOR HYPERTENSION: A SYSTEMATIC REVIEW OF GENOME-WIDE ASSOCIATION STUDIES

Genome-wide association analysis of hypertension and epigenetic aging reveals shared genetic architecture and identifies novel risk loci

Abstract 040: Comparative Genomic Analysis and Functional Insights for Blood Pressure-Associated Single Nucleotide Polymorphisms

A Genome-Wide Association Study of Hypertension and Blood Pressure in African Americans

Current Status of Genome-Wide Association Study

Assessment of polygenic risk of hypertension

FUNCTIONAL IN SILICO ANALYSIS OF GENETIC VARIANTS FROM GENOME-WIDE ASSOCIATION STUDIES OF BLOOD PRESSURE AND HYPERTENSION

Genetics of coronary artery disease in the post‐GWAS era

A cross-tissue transcriptome association study identifies key genes in essential hypertension

Systematic Characterization and Prediction of Human Hypertension Genes.

Genetic overlap for ten cardiovascular diseases: A comprehensive gene-centric pleiotropic association analysis and Mendelian randomization study